C₂N Diagnostics, LLC raised $15M in an investment from Eisai Inc. to scale up and provide broad access to its Precivity™ tests for Alzheimer’s disease pathology
Amount Raised
$15 Million
Round Type
Venture
St. LouisBiotechnologyHealth CareInvestors
Description
C₂N Diagnostics, LLC has announced an investment of up to 15 million USD from Eisai Inc. The investment aims to scale up and provide broad access to its Precivity™ tests for patients with cognitive impairment, helping healthcare providers determine Alzheimer’s disease pathology, and aid in medical management and treatment decisions.
Quick answer
C2N Diagnostics raised $15 Million in a funding round, dated March 6, 2024. Investors: Eisai Inc. C2N Diagnostics is based in St. Louis, Missouri, United States.
- How much did C2N Diagnostics raise?
- C2N Diagnostics raised $15 Million in a funding round on March 6, 2024.
- Who invested in C2N Diagnostics?
- Eisai Inc. is named as investors in this round.
- What does C2N Diagnostics do?
- C2N Diagnostics is a company focused on developing advanced diagnostic solutions in the field of brain health, particularly in the early diagnosis and treatment of Alzheimer's disease.
- Where is C2N Diagnostics based and how big is it?
- C2N Diagnostics is based in St. Louis, Missouri, United States. Fundz records about 120 employees.
- Who are the decision-makers at C2N Diagnostics?
- Fundz holds 1 contact at C2N Diagnostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as C2N Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- Diagnostic Support Services raised $660K (Seed) on April 19, 2024.
- Corner Therapeutics raised $54M (Series A) on April 19, 2024.
- Outrun Therapeutics raised $10M (Seed) on April 18, 2024.
- HealthSage raised $3.2M (Seed) on April 17, 2024.
- Theolytics raised $25M (Funding Round) on April 17, 2024.
- Isospec Analytics raised $1.9M (Pre-Seed) on April 16, 2024.
Who to call at C2N Diagnostics, and when
A new round usually means C2N Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day C2N Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at C2N Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at C2N Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment C2N Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
C2N Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.